Depression Treatments

​​​​​​​IV Ketamine

IV ketamine can be a powerful option for those struggling with persistent pain, depression, or anxiety — especially when traditional treatments haven’t helped. We use a safe, low-dose protocol designed for both physical and emotional relief.

​​​​​​​SPRAVATO® for Depression

SPRAVATO® (nasal esketamine) may help patients with treatment-resistant depression who haven’t responded to standard antidepressants. It can also be beneficial for those whose depression is associated with severe anxiety. Administered in a calm, supportive setting with medical supervision.

​​​​​​​Transcranial Magnetic Stimulation (TMS)

TMS is a noninvasive treatment that uses magnetic pulses to stimulate specific areas of the brain involved in mood regulation. It's FDA-approved for treatment-resistant depression and has shown promise in reducing symptoms of anxiety, PTSD, and chronic pain.

​​​​​​​Medical Evaluation & Care Planning

Your care starts and continues with in-depth, one-on-one visits that explore both physical and emotional contributors to your symptoms. Whether you’re dealing with chronic pain, anxiety, depression, or stress-related conditions, we take time to listen, connect the dots, and follow a plan that supports both your body and mind.

Treatment Guides

SPRAVATO, TMS, And IV KETAMINE COMPARISONS

Categories Spravato TMS Ketamine
Mechanism of Action Esketamine, the S-enantiomer of ketamine, acts as an NMDA receptor antagonist, modulating glutamate neurotransmission. TMS uses electromagnetic pulses to stimulate specific brain regions, primarily the left dorsolateral prefrontal cortex (DLPFC). Ketamine, an NMDA receptor antagonist, affects glutamate transmission, potentially enhancing synaptic plasticity and alleviating depression and pain.
Administration Self-administered via nasal spray under medical supervision by REMS-certified prescriber. Monitored in-office for 120 minutes. Non-invasive treatment involves placing a magnetic coil on the scalp to deliver pulsed magnetic stimuli to the brain. Takes less than 30 minutes. Administered intravenously (IV) over 1 to 3.5 hours, depending on the condition being treated.
Treatment Schedule Twice weekly for the first 4 weeks, followed by once weekly for 4 weeks, followed by maintenance dosing. Five days a week for about 6 weeks. Variable, generally a series of 8 infusions for chronic pain and 4 infusions for depression.
Potential Candidates Patients with Major Depressive Disorder, single episode or recurrent, moderate to severe. Failure of 2+ oral antidepressants. Patients with Major Depressive Disorder, single episode or recurrent, moderate to severe. Failure of 2-3+ oral antidepressants. Participation in psychotherapy. Patients seeking viable alternatives to conventional treatments for depression, Complex Regional Pain Syndrome (CRPS), and other types of chronic pain.
Insurance Generally authorized by insurance; coverage and out-of-pocket expenses vary by plan. Generally authorized by insurance; coverage and out-of-pocket expenses vary by plan. Unlikely to be covered by insurance.
Side Effects Common side effects include dissociation, dizziness, nausea, sedation, anxiety, increased blood pressure, and feeling "drunk". Common side effects include headaches, scalp discomfort, lightheadedness, facial muscle twitches, tingling. Rarely (0.1%), TMS may trigger transient seizures. Common side effects include dissociation, dizziness, nausea, sedation, anxiety, increased blood pressure, and feeling "drunk".
Drive Self to/from Treatment No Yes No